NO20025329L - Virulensgener, proteiner og deres anvendelse - Google Patents

Virulensgener, proteiner og deres anvendelse

Info

Publication number
NO20025329L
NO20025329L NO20025329A NO20025329A NO20025329L NO 20025329 L NO20025329 L NO 20025329L NO 20025329 A NO20025329 A NO 20025329A NO 20025329 A NO20025329 A NO 20025329A NO 20025329 L NO20025329 L NO 20025329L
Authority
NO
Norway
Prior art keywords
genes
proteins
virulence genes
virulence
products
Prior art date
Application number
NO20025329A
Other languages
English (en)
Other versions
NO20025329D0 (no
Inventor
Christoph Tang
Original Assignee
Microscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microscience Ltd filed Critical Microscience Ltd
Publication of NO20025329D0 publication Critical patent/NO20025329D0/no
Publication of NO20025329L publication Critical patent/NO20025329L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/36—Neisseria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO20025329A 2000-05-08 2002-11-06 Virulensgener, proteiner og deres anvendelse NO20025329L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0011108.8A GB0011108D0 (en) 2000-05-08 2000-05-08 Virulence gene and protein and their use
PCT/GB2001/002003 WO2001085772A2 (en) 2000-05-08 2001-05-08 Virulence genes, proteins, and their use

Publications (2)

Publication Number Publication Date
NO20025329D0 NO20025329D0 (no) 2002-11-06
NO20025329L true NO20025329L (no) 2003-01-06

Family

ID=9891203

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025329A NO20025329L (no) 2000-05-08 2002-11-06 Virulensgener, proteiner og deres anvendelse

Country Status (16)

Country Link
US (2) US20040087770A1 (no)
EP (2) EP1287024B1 (no)
JP (1) JP2003532404A (no)
KR (3) KR20030032948A (no)
CN (2) CN1840665A (no)
AT (1) ATE382056T1 (no)
AU (1) AU776508B2 (no)
CA (1) CA2408738A1 (no)
CZ (1) CZ20023642A3 (no)
DE (1) DE60132084T2 (no)
GB (1) GB0011108D0 (no)
HU (1) HUP0302481A2 (no)
NO (1) NO20025329L (no)
NZ (3) NZ522277A (no)
RU (2) RU2252224C2 (no)
WO (1) WO2001085772A2 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69526377T2 (de) 1994-12-09 2002-11-07 Microscience Ltd Virulenzgene in der VGC2-Region von Salmonella
WO2000014240A2 (en) 1998-09-04 2000-03-16 Creatogen Aktiengesellschaft Attenuated salmonella sp12 mutants as antigen carriers
US7666988B1 (en) 1999-03-12 2010-02-23 Glaxosmithkline Biologicals S.A. BASB082 Polypeptides
GB9910812D0 (en) 1999-05-10 1999-07-07 Microscience Ltd Vaccine composition
CA2493124C (en) * 2002-08-02 2014-04-29 Glaxosmithkline Biologicals S.A. Vaccine
GB0330007D0 (en) * 2003-12-23 2004-01-28 Imp College Innovations Ltd Vaccines
EP2425853A1 (en) 2005-04-08 2012-03-07 Wyeth LLC Multivalent Pneumococcal Polysaccharide-Protein Conjugate Composition
US7709001B2 (en) 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
EP2573080A1 (en) * 2007-09-27 2013-03-27 The United States of America, as Represented by the Secretary, Department of Health and Human Services Isoindoline compounds for the treatment of spinal muscular atrophy and other uses
US8703153B2 (en) 2008-06-16 2014-04-22 Prokarium Ltd. Salmonella vectored vaccines against Chlamydia and methods of use
GB0816447D0 (en) * 2008-09-08 2008-10-15 Glaxosmithkline Biolog Sa Vaccine
BR112012022800A2 (pt) * 2010-03-11 2018-05-15 Glaxosmithkline Biologicals Sa composição imunogênica ou vacina, cepa bacteriana gram-negativa geneticamente engenheirada, métodos para o tratamento ou prevenção de infecção ou doença, para produzir uma composição imunogênica ou uma vacina, e para preparar uma imunoglobulina, preparação da imunoglobulina, e, preparação farmacêutica
CN111118043B (zh) * 2020-01-13 2022-07-05 吉林大学 一种苦豆子SaMET6基因克隆及其应用
CN116042562B (zh) * 2022-03-11 2023-10-20 山东恒鲁生物科技有限公司 重组酵母菌及其应用
CN118388591B (zh) * 2023-11-24 2025-01-21 中国水产科学研究院黄海水产研究所 南极磷虾ace抑制肽apgr、fgaggl、lsgay及其应用
CN119080891B (zh) * 2024-11-11 2025-03-11 四川大学华西医院 鲍曼不动杆菌TonB重组蛋白抗原、制备方法及其应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE121947T1 (de) * 1989-12-14 1995-05-15 Ca Nat Research Council Verbessertes meningokokkale polysaccharidkonjugatvakzin.
CA2047043A1 (en) * 1990-07-19 1992-01-20 Allen I. Oliff Class ii protein of the outer membrane of neisseria meningitidis having immune enhancement properties
US5338664A (en) * 1992-12-04 1994-08-16 American Cyanamid Company Assay for detection of bacterial iron transport inhibitors
US6121037A (en) * 1994-10-18 2000-09-19 Stojiljkovic; Igor Bacterial hemoglobin receptor genes
DE69526377T2 (de) * 1994-12-09 2002-11-07 Microscience Ltd Virulenzgene in der VGC2-Region von Salmonella
FR2751000B1 (fr) * 1996-07-12 1998-10-30 Inst Nat Sante Rech Med Adn specifiques des bacteries de l'espece neisseria meningitidis, leurs procedes d'obtention et leurs applications biologiques
US6472518B1 (en) * 1996-10-24 2002-10-29 Centers For Disease Control And Prevention, As Represented By The Secretary, Department Of Health And Human Services Invasion associated genes from Neisseria meningitidis serogroup B
GB9711964D0 (en) * 1997-06-09 1997-08-06 Medical Res Council Live attenuated vaccines
BR9811907A (pt) * 1997-08-15 2000-08-15 Univ Utrecht Proteìna de ligação de lactoferrina de neisseria
EP1900818A3 (en) * 1997-11-06 2008-06-11 Novartis Vaccines and Diagnostics S.r.l. Neisserial antigens
BR9910005A (pt) * 1998-04-29 2001-01-16 American Cyanamid Co Composição de vacina, processos para imunização contra neisseria gonorrhoeae e para preparar uma composição de vacina, sequência de dna isolada e purificada, plasmìdeo, célula hospedeira, processo para produção de uma proteìna pilina recombinante quimérica de neisseria gonorrhoeae e neisseria meningitidis, proteìna pilina recombinante quimérica isolada e purificada de neisseria gonorhoeae e neisseria meningitidis, e, processo para imunização contra neisseria muningitidis
GB9811260D0 (en) * 1998-05-26 1998-07-22 Smithkline Beecham Biolog Novel compounds
MXPA01003557A (es) * 1998-10-09 2004-04-05 Chiron Corp Secuencias genomicas de neisseria y metodos para su uso.
US6610836B1 (en) * 1999-01-29 2003-08-26 Genome Therapeutics Corporation Nucleic acid amino acid sequences relating to Klebsiella pneumoniae for diagnostics and therapeutics
CA2371032A1 (en) * 1999-04-30 2000-11-09 Chiron Corporation Neisseria genomic sequences and methods of their use

Also Published As

Publication number Publication date
WO2001085772A2 (en) 2001-11-15
AU776508B2 (en) 2004-09-09
CN1427892A (zh) 2003-07-02
CZ20023642A3 (cs) 2003-04-16
US20040087770A1 (en) 2004-05-06
RU2252224C2 (ru) 2005-05-20
US20080241151A1 (en) 2008-10-02
KR20080080069A (ko) 2008-09-02
EP1908839A3 (en) 2008-07-16
CN1840665A (zh) 2006-10-04
RU2005101623A (ru) 2006-07-10
EP1287024B1 (en) 2007-12-26
CA2408738A1 (en) 2001-11-15
AU5242201A (en) 2001-11-20
EP1908839A2 (en) 2008-04-09
ATE382056T1 (de) 2008-01-15
NZ549068A (en) 2008-03-28
EP1287024A2 (en) 2003-03-05
KR20070102447A (ko) 2007-10-18
NZ532297A (en) 2005-07-29
NO20025329D0 (no) 2002-11-06
DE60132084D1 (de) 2008-02-07
KR20030032948A (ko) 2003-04-26
DE60132084T2 (de) 2008-12-11
NZ522277A (en) 2004-05-28
HUP0302481A2 (hu) 2003-10-28
WO2001085772A3 (en) 2002-03-28
JP2003532404A (ja) 2003-11-05
GB0011108D0 (en) 2000-06-28

Similar Documents

Publication Publication Date Title
NO20025329D0 (no) Virulensgener, proteiner og deres anvendelse
IS6895A (is) Aðferð til að bera kennsl á, einangra og vinna mótefnavaka við ákveðnum sjúkdómsvaldi
EP1322328A4 (en) VACCINES FOR BROAD SPECTRUM PROTECTION AGAINST DISEASES CAUSED BY NEISSERIA MENINGITIDIS
DE69932717D1 (de) Methoden und produkte zur induzierung mukosaler immunität
CY1107950T1 (el) Νεϊσσεριακες συνθεσεις εμβολιου και μεθοδοι
ATE427114T1 (de) Verwendung von hepcidin zur herstellung eines arzneimittels zur behandlung von eisenhomíostase stírungen
NZ515936A (en) Antigenic Neisserial peptides
DK1471936T3 (da) HIV-Vaccine og fremgangsmåde til anvendelse
NO20023006L (no) Virulens gener, proteiner og deres anvendelse
NO20050063L (no) 2-heteroaryl karboksamider
ATE413888T1 (de) Salmonella vakzine
NO20013102D0 (no) Gener, proteiner og deres anvendelse
NZ511366A (en) Virulence genes and proteins, and their use
DE60126765D1 (de) Virulenz gene, proteine, und ihre verwendung
NO20062469L (no) Streptococcus phocae vaksine
DE602005025202D1 (de) Subtilasevarianten mit veränderter immunogenität
DK1313850T3 (da) Nucleinsyre og tilsvarende protein med navnet 85PB3 anvendelige til behandling og påvisning af cancer
WO2002016612A3 (en) Genes and proteins, and their uses
DK1074266T3 (da) Levende svækkede bakterier til anvendelse i vaccine
PE20020525A1 (es) Composiciones que comprende sales de tiotropio y agentes antihistaminicos
WO2001057075A3 (en) Virulence genes, proteins, and their use
DE60024977D1 (de) Klonierung und expression von haemophilus somnus transferrin-bindenden proteinen
BR0308180A (pt) protéinas de superfìcie de leptospira
DE602005020915D1 (de) Mannose-spezifische adhesinen und deren vervendung
ATE166880T1 (de) Impfstoff gegen cholera

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application